Ligand validation:2Y0K

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 2Y0K designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y0K_C8E_A_1390	47%	83%	0.095	0.943	0.32	0.46	-	-	0	0	38%	0.381
2Y0K_C8E_A_1387	26%	76%	0.152	0.849	0.4	0.54	-	-	0	0	67%	0.6667
2Y0K_C8E_A_1388	22%	85%	0.178	0.869	0.38	0.37	-	-	1	0	57%	0.5714
2Y0K_C8E_A_1394	19%	80%	0.172	0.859	0.35	0.49	-	-	2	0	48%	0.4762
2Y0K_C8E_A_1391	17%	90%	0.193	0.89	0.46	0.15	-	-	0	0	33%	0.3333
2Y0K_C8E_A_1385	14%	77%	0.22	0.861	0.38	0.53	-	-	0	0	52%	0.5238
2Y0K_C8E_A_1393	12%	87%	0.192	0.783	0.41	0.29	-	-	0	0	62%	0.619
2Y0K_C8E_A_1395	9%	80%	0.256	0.873	0.39	0.45	-	-	0	0	33%	0.3333
2Y0K_C8E_A_1386	5%	85%	0.186	0.715	0.47	0.27	-	-	0	0	29%	0.2857
2Y0K_C8E_A_1389	3%	88%	0.367	0.829	0.47	0.21	-	-	0	0	43%	0.4286
2Y0K_C8E_A_1392	3%	81%	0.252	0.602	0.46	0.36	-	-	0	0	100%	1
3SZV_C8E_A_386	70%	86%	0.088	0.92	0.39	0.34	-	-	1	0	90%	0.9048
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.